Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.68 USD | -3.72% | +6.46% | +108.12% |
May. 02 | Dyne Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | Morgan Stanley Starts Dyne Therapeutics With Overweight Rating, $40 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 14.06M | Capitalization | 2.42B |
---|---|---|---|---|---|
Net income 2024 * | -259M | Net income 2025 * | -292M | EV / Sales 2024 * | - |
Net cash position 2024 * | 191M | Net cash position 2025 * | 301M | EV / Sales 2025 * | 151 x |
P/E ratio 2024 * |
-8.92
x | P/E ratio 2025 * |
-8.45
x | Employees | 143 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.45% |
1 day | -3.72% | ||
1 week | +6.46% | ||
Current month | +9.36% | ||
1 month | +11.52% | ||
3 months | +20.82% | ||
6 months | +151.18% | ||
Current year | +108.12% |
Managers | Title | Age | Since |
---|---|---|---|
Jason Rhodes
FOU | Founder | 54 | 17-11-30 |
Rick Scalzo
DFI | Director of Finance/CFO | 38 | 19-11-30 |
John Najim
CTO | Chief Tech/Sci/R&D Officer | 48 | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Hurwitz
BRD | Director/Board Member | 60 | 18-10-31 |
David Lubner
BRD | Director/Board Member | 60 | 20-02-29 |
Dirk Kersten
BRD | Director/Board Member | 49 | 18-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - | |
0.02% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 27.68 | -3.72% | 1,318,232 |
24-05-16 | 28.75 | -2.14% | 1,120,645 |
24-05-15 | 29.38 | +4.33% | 1,011,777 |
24-05-14 | 28.16 | +5.79% | 650,219 |
24-05-13 | 26.62 | +2.38% | 959,621 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+108.12% | 2.42B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- DYN Stock